Singapore vs Saint Vincent and the Grenadines: Young people (ages 15-24) newly infected with HIV
Singapore
100
in 2023
Saint Vincent and the Grenadines
100
in 2024
Singapore rank
83rd
Saint Vincent and the Grenadines rank
83rd
Young people (ages 15-24) newly infected with HIV over time
- Singapore
- Saint Vincent and the Grenadines
How they compare
Singapore currently reports 100 against 100 in Saint Vincent and the Grenadines, a difference of 0.
Across all 34 years both countries report, Saint Vincent and the Grenadines has been ahead every year.
Singapore ranks 83rd and Saint Vincent and the Grenadines ranks 83rd of 137 countries.
Head to head by decade
| Decade | Singapore | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 100 | 100 | 0 | — |
| 2000s | 100 | 100 | 0 | — |
| 2010s | 100 | 100 | 0 | — |
| 2020s | 100 | 100 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher young people (ages 15-24) newly infected with hiv, Singapore or Saint Vincent and the Grenadines?
- Singapore, at 100 against 100 in Saint Vincent and the Grenadines as of 2023.
- What is the difference in young people (ages 15-24) newly infected with hiv between Singapore and Saint Vincent and the Grenadines?
- 0, with Singapore ahead.
- How many years of comparable data are there for Singapore and Saint Vincent and the Grenadines?
- 34 years are reported by both, from 1990 to 2023.
- How do Singapore and Saint Vincent and the Grenadines rank globally for young people (ages 15-24) newly infected with hiv?
- Singapore ranks 83rd and Saint Vincent and the Grenadines ranks 83rd of 137 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Young people (ages 15-24) newly infected with HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of young people (ages 15-24) newly infected with HIV.